Mid-regional pro-adrenomedullin (MR-proADM): an even better prognostic biomarker than C-reactive protein to predict short-term survival in patients with decompensated cirrhosis at risk of infection? - Reuken, P A; Kiehntopf, M; Stallmach, A; Bruns, T (J Hepatol, 2012)
, author reply 1158–1159